People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Verax Biomedical Inc | — | Biotechnology | Series A | $45.8M | $91.8M | 2009 |
| Cambridge Endoscopic Devices Inc | — | Biotechnology | Seed | $12.0M | $129.8M | 2010 |
| Triopsy Medical, Inc. | — | Healthtech | Seed | $4.1M | $570K | 2022 |
James Lousararian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Lousararian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Goldberg | 1 | 9 |
| Buzz Benson | 1 | 8 |
| Walter Winshall | 1 | 6 |
| ROBERT ZIESERL | 1 | 5 |
| Robert Flanagan | 1 | 4 |
| JOE DEL GUERCIO | 1 | 4 |
| MARC E. GOLDBERG | 1 | 4 |
| Brad Buscher | 1 | 4 |
| Jeff Barnes | 1 | 4 |
| John Harper | 1 | 3 |
| Richard Larson | 1 | 3 |
| John Schulte | 1 | 3 |
| Glen Kashuba | 1 | 3 |
| Nelson Stone | 1 | 3 |
| JAMES KOZIARZ | 1 | 2 |
| Todd Anderson | 1 | 2 |
| Omar Amirana | 1 | 2 |
| HOWARD DONNELLY | 1 | 2 |
| JEFFREY A. HALL | 1 | 1 |
| NANCY A. HORNBAKER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.